Strategies and advances in immunotherapy of non-small cell lung cancer
LU Chang
WANG Aman
LI Ying
Ning Zhen
LIU Jiwei
Abstract：Non-small cell lung cancer(NSCLC) is a highly prevalent and aggressive disease. In recent years, the long time survival rate of patients with advanced NSCLC remains low despite of advances in surgery, irradiation, chemotherapy and targeted ther-apy. The aim of immunotherapy is to specifically enhance the immune response directed to the tumor. Many trials have addressed the role of novel immunotherapeutic agents, such as checkpoint inhibitors and antigenspecific tumour vaccines, which has made break-through progress in NSCLC. Immunotherapy will be a fundamentally new concept for the treatment of NSCLC.
Keywords：ImmunotherapyNon-small cell lung cancer(NSCLC)Checkpoint inhibitorsTumor vaccines
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 452-457 )